Since Banque Du Liban issued the circular that was supposed to protect the importers of pharmaceutical products from the manipulation of the US dollar exchange, the importers have been calling for amending the decision so that they can benefit from it.
But their demands have been falling on deaf ears, which can cause a shortage in medicine in the market if the situation remains unchanged.
For more details, watch the full report in the video above